Overview

A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
A study to evaluate how much of the active compound of mirabegron comes into the blood circulation when given as a controlled-release pill as compared to given intravenously.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mirabegron